The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Vitamin C Inhibits NF-κB Activation by TNF Via the Activation of p38 Mitogen-Activated Protein Kinase
Open accessAbstract
The transcription factor NF-κB is a central mediator of altered gene expression during inflammation, and is implicated in a number of pathologies, including cancer, atherosclerosis, and viral infection. We report in this study that vitamin C inhibits the activation of NF-κB by multiple stimuli, including IL-1 and TNF in the endothelial cell line ECV304 and in primary HUVECs. The induction of a NF-κB-dependent gene, IL-8, by TNF was also inhibited. The effect requires millimolar concentrations of vitamin C, which occur intracellularly in vivo, particularly during inflammation. Vitamin C was not toxic to cells, did not inhibit another inducible transcription factor, STAT1, and had no effect on the DNA binding of NF-κB. Inhibition by vitamin C was not simply an antioxidant effect, because redox-insensitive pathways to NF-κB were also blocked. Vitamin C was shown to block IL-1- and TNF-mediated degradation and phosphorylation of I-κBα (inhibitory protein that dissociates from NF-κB), due to inhibition of I-κB kinase (IKK) activation. Inhibition of TNF-driven IKK activation was mediated by p38 mitogen-activated protein kinase, because treatment of cells with vitamin C led to a rapid and sustained activation of p38, and the specific p38 inhibitor SB203580 reversed the inhibitory effect of vitamin C on IKK activity, I-κBα phosphorylation, and NF-κB activation. The results identify p38 as an intracellular target for high dose vitamin C.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
[43] Malondialdehyde determination as index of lipid Peroxidation
Draper, H. H., & Hadley, M. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86135-i · Cited by 4,292
Recommended Dietary Allowances.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-822_3 · Cited by 3,905
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,001
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7420 · Cited by 2,241
Cited by
The IKK NF-κB system: a treasure trove for drug development
Karin, M., Yamamoto, Y., & Wang, Q. M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1279 · Cited by 1,364
Changes in Proinflammatory Cytokine Activity after Menopause
Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 914
TNF and MAP kinase signalling pathways
Sabio, G., & Davis, R. J. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.02.009 · Cited by 700
Carluccio, M. A., Siculella, L., Ancora, M. A., Massaro, M., Scoditti, E., Storelli, C., Visioli, F., Distante, A., & De Caterina, R. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000062884.69432.a0 · Cited by 640
The Endoplasmic Reticulum: Folding, Calcium Homeostasis, Signaling, and Redox Control
Görlach, A., Klappa, P., & Kietzmann, D. T. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1391 · Cited by 615
New developments and novel therapeutic perspectives for vitamin C
Li, Y., & Schellhorn, H. E. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.10.2171 · Cited by 508
Antioxidative and anti-inflammatory activity of ascorbic acid
Gęgotek, A., & Skrzydlewska, E. (2022) · Antioxidants · doi:10.3390/antiox11101993 · Cited by 420
Yoo, K. M., Lee, K. W., Park, J. B., Lee, H. J., & Hwang, I. K. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0498158 · Cited by 377
The many paths to p38 mitogen-activated protein kinase activation in the immune system
Ashwell, J. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1865 · Cited by 370
Natural products as targeted modulators of the nuclear factor-κ B pathway
Bremner, P., & Heinrich, M. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021778637 · Cited by 312
Oudemans-van Straaten, H. M., Man, A. M. S.-D., & de Waard, M. C. (2014) · Critical Care · doi:10.1186/s13054-014-0460-x · Cited by 299
The subendothelial extracellular matrix modulates NF-κB activation by flow
Orr, A. W., Sanders, J. M., Bevard, M., Coleman, E., Sarembock, I. J., & Schwartz, M. A. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200410073 · Cited by 283
Vitamin C Suppresses TNFα-Induced NFκB Activation by Inhibiting IκBα Phosphorylation
Cárcamo, J. M., Pedraza, A., Bórquez-Ojeda, O., & Golde, D. W. (2002) · Biochemistry · doi:10.1021/bi0263210 · Cited by 280
Immunomodulatory and antimicrobial effects of vitamin C
Mousavi, S., Bereswill, S., & Heimesaat, M. M. (2019) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2019.00016 · Cited by 266
Härtel, C., Strunk, T., Bucsky, P., & Schultz, C. (2004) · Cytokine · doi:10.1016/j.cyto.2004.02.004 · Cited by 175
Intravenous Vitamin C and Cancer: A Systematic Review
Fritz, H., Flower, G., Weeks, L., Cooley, K., Callachan, M., McGowan, J., Skidmore, B., Kirchner, L., & Seely, D. (2014) · Integrative Cancer Therapies · doi:10.1177/1534735414534463 · Cited by 124
“Several preclinical studies demonstrate the ability of vitamin C to inhibit TNF-α induced activation of NF-κB in cancer cells.(81,82,87) The reason why some patients appear to respond favorably to IVC therapy, such as those documented in case reports, while others have not is unclear.”
BackgroundIntravenous vitamin C in the supportive care of cancer patients: A review and rational approach
Klimant, E., Wright, H., Rubin, D., Seely, D., & Markman, M. (2018) · Current Oncology · doi:10.3747/co.25.3790 · Cited by 99
Wood, L. G. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201702-124aw · Cited by 99
Kang, J. S., Kim, H. N., Jung, D. J., Kim, J. E., Mun, G. H., Kim, Y. S., Cho, D., Shin, D. H., Hwang, Y.-I., & Lee, W. J. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700572 · Cited by 88
“According to the report by Bowie and O’Neill (2000), p38MAPK is the intracellular target molecule of vitamin C.”
BackgroundVitamin C supplementation for diabetes management: A comprehensive narrative review
Mason, S. A., Parker, L., van der Pligt, P., & Wadley, G. D. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.12.003 · Cited by 53
Pharmaconutrition Review: Physiological Mechanisms
Pierre, J. F., Heneghan, A. F., Lawson, C. M., Wischmeyer, P. E., Kozar, R. A., & Kudsk, K. A. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113493326 · Cited by 51
Metadata
- Authors
- Bowie, A. G., & O’Neill, L. A. J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-12
- Volume
- 165
- Issue
- 12
- Pages
- 7180-7188
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2138521238
- Cited by
- 315
- References
- 64
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.